President & CEOOfficers of the CorporationBoard of TrusteesFoundation BoardLeadership CouncilAbout Joslin ResearchAdvocacy & Gov't AffairsHistory
Newly DiagnosedManaging DiabetesChildhood DiabetesNutritionExerciseOnline Diabetes ClassesDiscussion BoardsJoslin Clinical ResearchInfo for Healthcare ProfessionalsJoslin Clinical Guidelines
Make an AppointmentmyJoslin | Patient PortalAdult ClinicYoung Adult Transition CarePediatricsEye CareWeight Management ProgramsDO ITMental Health & CounselingReferring PhysiciansBillingAfrican American ProgramsAsian ClinicLatino Diabetes InitiativeAbout Joslin ResearchVolunteer for Clinical Research StudiesInfo for Healthcare ProfessionalsClinical Guidelines
Directory of Joslin InvestigatorsDiabetes Research Center Alumni ConnectionVolunteer for Clinical Research Studies
Media RelationsNews ReleasesInside JoslinSocial Media
Affiliated CentersPharma & DeviceCorporate EducationPublicationsProfessional EducationInternationalCause MarketingHealthcare ProfessionalsCommercialization and VenturesJoslin Institute for Technology Translation (JITT)
Give NowHigh Hopes FundWays to GivePlanned GivingEventsGet InvolvedCorporate & Foundation SupportOur DonorsDevelopment Team

Peter Amenta

On October 21, 2008 Peter S. Amenta, MD, PhD was named Dean of UMDNJ-Robert Wood Johnson Medical School, after serving as Interim Dean for more than two years.  Dr. Amenta, received his Bachelor of Science degree from Trinity College in Hartford Connecticut.  He completed his Medical Degree and Pathology residency at Hahnemann University in Philadelphia, PA, where he also obtained a PhD in Anatomy and initiated his studies on the pathobiology of the connective tissues in the laboratory of Antonio Martinez-Hernandez, MD.

A member of the UMDNJ-Robert Wood Johnson Medical School (RWJMS) faculty since 1989, he served as Residency Program Director and Chief of the Pathology Service at Robert Wood Johnson University Hospital for more than a decade.  He also served as chair of the Performance Improvement Committee at the Hospital for 8 years and Senior Vice President of Medical Affairs and Chief of Staff from 2002-2006.  He was Chair of the Department of Pathology and Laboratory Medicine from 1998 - 2008. In addition, he was the founding Director of the Cancer Institute of New Jersey’s Immunohistochemistry Shared Resource and a member of the Institute’s Scientific Council and Internal Advisory Board. 

Dr. Amenta is an expert electron microscopist and immunohistochemist.  His studies have contributed to our understanding of the tissue localization, inter-relationships and potential role of a number of novel connective tissue components during development and in normal and pathologic tissue.   His major clinical interest is in the study of gastrointestinal diseases.   He has collaborated with investigators throughout UMDNJ and other institutions nationally and has contributed to a number of grant-funded projects.  He is a member of the Board of Trustees of the Harvard Medical School associated Joslin Diabetes Center.

He has served on the Editorial Board of Human Pathology and as an invited reviewer for numerous other journals. He has published more than 150 articles, chapters and abstracts, including co-editing the textbook Histology-From Normal Microanatomy to Pathology.

During his tenure as dean the institution restructured its basic science departmental organization around scientific disciplines of the investigators, experienced a 30% increase in clinical revenue, restructured and modernized its clinical practice, recruited key faculty to signature programs, implemented a state-of-the-art electronic health record, modernized its curriculum, expanded its community-based clinical sites, developed the Child Health Institute of New Jersey as the key research arm of the premier academic pediatric campus in the state of New Jersey, dedicated the Cardiovascular Institute and transitioned into Rutgers University.

 

Page last updated: October 23, 2014